HKMPY
Price
$46.95
Change
-$1.05 (-2.19%)
Updated
Sep 3 closing price
Capitalization
5.15B
HLTRF
Price
$3.80
Change
-$0.00 (-0.00%)
Updated
Aug 27 closing price
Capitalization
126.35M
Interact to see
Advertisement

HKMPY vs HLTRF

Header iconHKMPY vs HLTRF Comparison
Open Charts HKMPY vs HLTRFBanner chart's image
Hikma Pharmaceuticals
Price$46.95
Change-$1.05 (-2.19%)
Volume$420
Capitalization5.15B
HLS Therapeutics
Price$3.80
Change-$0.00 (-0.00%)
Volume$100
Capitalization126.35M
HKMPY vs HLTRF Comparison Chart in %
Loading...
HKMPY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
HLTRF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
HKMPY vs. HLTRF commentary
Sep 09, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is HKMPY is a Hold and HLTRF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 09, 2025
Stock price -- (HKMPY: $45.87 vs. HLTRF: $3.80)
Brand notoriety: HKMPY and HLTRF are both not notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: HKMPY: 255% vs. HLTRF: 2%
Market capitalization -- HKMPY: $5.15B vs. HLTRF: $126.35M
HKMPY [@Pharmaceuticals: Generic] is valued at $5.15B. HLTRF’s [@Pharmaceuticals: Generic] market capitalization is $126.35M. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $67.25B to $0. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $3.96B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

HKMPY’s FA Score shows that 1 FA rating(s) are green whileHLTRF’s FA Score has 1 green FA rating(s).

  • HKMPY’s FA Score: 1 green, 4 red.
  • HLTRF’s FA Score: 1 green, 4 red.
According to our system of comparison, HLTRF is a better buy in the long-term than HKMPY.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

HKMPY’s TA Score shows that 4 TA indicator(s) are bullish while HLTRF’s TA Score has 3 bullish TA indicator(s).

  • HKMPY’s TA Score: 4 bullish, 5 bearish.
  • HLTRF’s TA Score: 3 bullish, 4 bearish.
According to our system of comparison, HKMPY is a better buy in the short-term than HLTRF.

Price Growth

HKMPY (@Pharmaceuticals: Generic) experienced а -7.61% price change this week, while HLTRF (@Pharmaceuticals: Generic) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was +0.81%. For the same industry, the average monthly price growth was +9.99%, and the average quarterly price growth was +86.92%.

Industries' Descriptions

@Pharmaceuticals: Generic (+0.81% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
HKMPY($5.15B) has a higher market cap than HLTRF($126M). HLTRF YTD gains are higher at: 41.264 vs. HKMPY (-2.983). HKMPY has higher annual earnings (EBITDA): 734M vs. HLTRF (15.5M). HKMPY has more cash in the bank: 236M vs. HLTRF (12.2M). HLTRF has less debt than HKMPY: HLTRF (55.6M) vs HKMPY (1.56B). HKMPY has higher revenues than HLTRF: HKMPY (3.22B) vs HLTRF (56.4M).
HKMPYHLTRFHKMPY / HLTRF
Capitalization5.15B126M4,083%
EBITDA734M15.5M4,735%
Gain YTD-2.98341.264-7%
P/E Ratio13.73N/A-
Revenue3.22B56.4M5,702%
Total Cash236M12.2M1,934%
Total Debt1.56B55.6M2,802%
FUNDAMENTALS RATINGS
HKMPY vs HLTRF: Fundamental Ratings
HKMPY
HLTRF
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
10
Undervalued
26
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
8896
PRICE GROWTH RATING
1..100
8144
P/E GROWTH RATING
1..100
96100
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

HKMPY's Valuation (10) in the null industry is in the same range as HLTRF (26). This means that HKMPY’s stock grew similarly to HLTRF’s over the last 12 months.

HKMPY's Profit vs Risk Rating (100) in the null industry is in the same range as HLTRF (100). This means that HKMPY’s stock grew similarly to HLTRF’s over the last 12 months.

HKMPY's SMR Rating (88) in the null industry is in the same range as HLTRF (96). This means that HKMPY’s stock grew similarly to HLTRF’s over the last 12 months.

HLTRF's Price Growth Rating (44) in the null industry is somewhat better than the same rating for HKMPY (81). This means that HLTRF’s stock grew somewhat faster than HKMPY’s over the last 12 months.

HKMPY's P/E Growth Rating (96) in the null industry is in the same range as HLTRF (100). This means that HKMPY’s stock grew similarly to HLTRF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
HKMPYHLTRF
RSI
ODDS (%)
Bullish Trend 5 days ago
53%
Bearish Trend 5 days ago
52%
Stochastic
ODDS (%)
Bullish Trend 5 days ago
38%
Bearish Trend 6 days ago
57%
Momentum
ODDS (%)
Bearish Trend 5 days ago
55%
Bullish Trend 6 days ago
40%
MACD
ODDS (%)
Bearish Trend 5 days ago
46%
Bearish Trend 5 days ago
53%
TrendWeek
ODDS (%)
Bearish Trend 5 days ago
60%
Bullish Trend 5 days ago
50%
TrendMonth
ODDS (%)
Bearish Trend 5 days ago
59%
Bullish Trend 5 days ago
47%
Advances
ODDS (%)
Bullish Trend 22 days ago
55%
Bullish Trend 23 days ago
50%
Declines
ODDS (%)
Bearish Trend 7 days ago
64%
N/A
BollingerBands
ODDS (%)
Bullish Trend 5 days ago
37%
Bearish Trend 5 days ago
57%
Aroon
ODDS (%)
Bearish Trend 5 days ago
66%
Bullish Trend 5 days ago
50%
View a ticker or compare two or three
Interact to see
Advertisement
HKMPY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
HLTRF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
KPDD23.910.31
+1.31%
KraneShares 2x Long PDD Daily ETF
EMC29.990.37
+1.24%
Global X Emerging Mkts Great Cnsmr ETF
JPEM58.530.46
+0.79%
JPMorgan Diversified Return EMkts Eq ETF
TIPX19.350.05
+0.26%
SPDR® Blmbg 1-10 Year TIPS ETF
MSFX32.11-1.80
-5.30%
T-Rex 2X Long Microsoft Daily Target ETF

HKMPY and

Correlation & Price change

A.I.dvisor tells us that HKMPY and HYPMY have been poorly correlated (+14% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that HKMPY and HYPMY's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HKMPY
1D Price
Change %
HKMPY100%
N/A
HYPMY - HKMPY
14%
Poorly correlated
+1.57%
JUSHF - HKMPY
5%
Poorly correlated
+6.59%
HLTRF - HKMPY
4%
Poorly correlated
N/A
INDV - HKMPY
3%
Poorly correlated
+1.01%
GTBIF - HKMPY
2%
Poorly correlated
+4.55%
More

HLTRF and

Correlation & Price change

A.I.dvisor indicates that over the last year, HLTRF has been loosely correlated with PHCUF. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if HLTRF jumps, then PHCUF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HLTRF
1D Price
Change %
HLTRF100%
N/A
PHCUF - HLTRF
38%
Loosely correlated
N/A
INCR - HLTRF
21%
Poorly correlated
+0.27%
GTBIF - HLTRF
3%
Poorly correlated
+4.55%
ESALF - HLTRF
3%
Poorly correlated
+0.06%
INDV - HLTRF
2%
Poorly correlated
+1.01%
More